The Bureau of Historic Losses · Counterfactual Division
What if you'd bought Novo Nordisk in 2021?
Wegovy won US approval in 2021 and the GLP-1 weight-loss wave began in earnest — Novo Nordisk would soon become Europe's most valuable company. Buying here caught the take-off, demand so fierce it couldn't make the drug fast enough.
$100 on 2021-01-04, worth today
US$139
As of 2026-06-12, $100 of Novo Nordisk bought at 2021's open (US$31.63) is worth US$139 — 1.39×.
total return · dividends reinvested · USD
How much would $100 of Novo Nordisk bought in 2021 be worth today?
| You'd have put in | You'd have now | Multiple |
|---|---|---|
| US$100 | US$139 | 1.39× |
| US$1,000 | US$1,387 | 1.39× |
| US$10,000 | US$13,873 | 1.39× |
Lump sum on the year's first trading day, total return (dividends reinvested, splits adjusted), valued at the latest close. Past performance isn't a promise — it's a taunt.
What did Novo Nordisk do in 2021?
Opened
US$31.63
2021-01-04
Peaked
US$52.87
2021-12-16
Bottomed
US$29.70
2021-03-24
Closed
US$50.58
2021-12-31
Levels are dividend-adjusted, so historical figures look lower than the headline price of the day — that's the total-return lens, and it's the honest one.
Would steady buying have beaten going all in?
US$28,500 deployed as $100 a week from 2021-01-04, under four temperaments — same money, different nerves.
| All in on day one | US$39,537 |
| Steady weekly buys | US$21,829 |
| Sold dips, rebought rallies | US$31,708 |
| Traded it perfectly | US$55,795 |
“Traded it perfectly” requires knowing the future. Nobody knew the future.
The same $1,000, elsewhere
$1,000 at 2021's open, each valued at the latest close. Hindsight remains undefeated.
These were the round numbers. Run your real ones.
Your amount, your date, your certificate. Takes about a minute.
Calculate my failureAdjacent timelines